This page has not been authorized, sponsored, or otherwise approved or endorsed by the companies represented herein. Each of the company logos represented herein are trademarks of Microsoft Corporation; Dow Jones & Company; Nasdaq, Inc.; Forbes Media, LLC; Investor's Business Daily, Inc.; and Morningstar, Inc.
Copyright 2025 Zacks Investment Research | 101 N Wacker Drive, Floor 15, Chicago, IL 60606
At the center of everything we do is a strong commitment to independent research and sharing its profitable discoveries with investors. This dedication to giving investors a trading advantage led to the creation of our proven Zacks Rank stock-rating system. Since 1988 it has more than doubled the S&P 500 with an average gain of +23.81% per year. These returns cover a period from January 1, 1988 through September 1, 2025. Zacks Rank stock-rating system returns are computed monthly based on the beginning of the month and end of the month Zacks Rank stock prices plus any dividends received during that particular month. A simple, equally-weighted average return of all Zacks Rank stocks is calculated to determine the monthly return. The monthly returns are then compounded to arrive at the annual return. Only Zacks Rank stocks included in Zacks hypothetical portfolios at the beginning of each month are included in the return calculations. Zacks Ranks stocks can, and often do, change throughout the month. Certain Zacks Rank stocks for which no month-end price was available, pricing information was not collected, or for certain other reasons have been excluded from these return calculations. Zacks may license the Zacks Mutual Fund rating provided herein to third parties, including but not limited to the issuer.
Visit Performance Disclosure for information about the performance numbers displayed above.
Visit www.zacksdata.com to get our data and content for your mobile app or website.
Real time prices by BATS. Delayed quotes by Sungard.
NYSE and AMEX data is at least 20 minutes delayed. NASDAQ data is at least 15 minutes delayed.
This site is protected by reCAPTCHA and the Google Privacy Policy, DMCA Policy and Terms of Service apply.
View All Zacks #1 Ranked Stocks
Zacks News
UnitedHealth Group, Inc. is the largest health care services company in the world, serving over 50 million individuals in the United States as of 2019 and over 5 million internationally. The company provides a wide range of health care products and services, such as health maintenance organizations (HMOs), point of service plans (POS), preferred provider organizations (PPOs), and managed fee-for-service programs. UnitedHealth has the largest and most diverse membership base within the managed-care organization market, which gives it significant competitive advantages. It also has built its prescription drug business through OptumRx division, with the acquisition of Catamaran in 2015.
4 Reasons Why UnitedHealth (UNH) Stock Looks Attractive Now
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) remains the leader in the health insurance industry by virtue of its vast scale and tremendously diversified operations.
Molina Hit by Public Exchanges, Failed Aetna-Humana Merger
by Zacks Equity Research
Molina Healthcare Inc. (MOH) continues to suffer from ongoing issues related to the Affordable Care Act's insurance Marketplace.
UnitedHealth Extends Expiration Date of SCA Share Exchange
by Zacks Equity Research
UnitedHealth Group Incorporated (UNH) recently declared that the expiration of its previously announced exchange offer for all of the outstanding shares of Surgical Care Affiliates, Inc. (SCAI) ("SCA???) has been extended.
UnitedHealth's Senior Unsecured Notes Rated by A.M Best
by Zacks Equity Research
UnitedHealth Group, Inc.'s (UNH) senior unsecured notes recently received rating action from A.M Best.
UnitedHealth's (UNH) Senior Unsecured Debt Rated by Moody's
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) recently announced that its senior unsecured debt has been assigned an A3 rating by Moody's Investors Service, a wing of Moody???s Corporation (MCO).
Trump Promises Interstate Coverage Sales, Will It Help Insurance Stocks?
by Ryan McQueeney
Just a day after Republicans unveiled their highly-anticipated plan to repeal and replace Obamacare, President Donald Trump has taken to Twitter to promise that one key provision--eliminating state lines for insurance sales--will come at a later phase in the healthcare rollout.
Teladoc (TDOC) Q4 Loss Lower Than Expected, Guides for '17
by Zacks Equity Research
Teladoc Inc.'s (TDOC) fourth-quarter operating loss of 31 cents per share came in narrower than the Zacks Consensus Estimate of a loss of 35 cents per share.
Select Medical (SEM) Q4 Earnings Miss, Keeps 2017 Guidance
by Zacks Equity Research
Select Medical Holdings Corp. (SEM) reported fourth-quarter 2016 earnings of 12 cents per share, which missed the Zacks Consensus Estimate by a couple of cents.
Tenet Healthcare (THC) Q4 Earnings & Revenues Miss Estimates
by Zacks Equity Research
Tenet Healthcare Corp. (THC) reported fourth-quarter 2016 operating earnings of 6 cents per share that missed the Zacks Consensus Estimate of 20 cents by 70%.
Top Research Reports for February 22, 2017
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including UnitedHealth (UNH), General Mills (GIS) and Public Storage (PSA).
Community Health Systems (CYH) Q4 Earnings Beat Estimates
by Zacks Equity Research
Community Health Systems, Inc. (CYH) reported adjusted earnings of 46 cents per share in the fourth quarter of 2016, which crushed the Zacks Consensus Estimate of 12 cents by 283%
UnitedHealth Hits 52-Week High on Solid Results, SCAI Deal
by Zacks Equity Research
UnitedHealth Group Inc. (UNH) touched a 52-week highdriven by robust fourth-quarter earnings, strong 2017 guidance and the acquisition of Surgical Care.
Why Is UnitedHealth (UNH) Up 4.2% Since the Last Earnings Report?
by Zacks Equity Research
UnitedHealth (UNH) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Molina Healthcare (MOH) Q4 Earnings, Revenues Miss Estimates
by Zacks Equity Research
Molina Healthcare Inc. (MOH) reported fourth-quarter 2016 adjusted net income per share of 63 cents, missing the Zacks Consensus Estimate of 75 cents by 16%.
Will Health Insurers Face the Music of Trump's Policies?
by Zacks Equity Research
After having adjusted to tthe ACA policy, insurers might have to reassess their business strategies in the wake of the Trump presidency.
Humana (HUM) Beats on Earnings, Misses Revenues in Q4
by Zacks Equity Research
Humana Inc.'s (HUM) fourth-quarter 2016 operating earnings per share of $2.09, which beat the Zacks Consensus Estimate of $2.06 roughly by 1.4%.
Express Scripts (ESRX) Q4 Earnings: What's in the Cards?
by Zacks Equity Research
Express Scripts Holding Company (ESRX), is scheduled to report fourth-quarter 2016 results on Feb 14 after market closes.
Will Q4 Earnings Hold a Surprise for DaVita (DVA) Stock?
by Zacks Equity Research
DaVita HealthCare Partners Inc. (DVA) is set to report fourth-quarter 2016 results after market close on Feb 9.
WellCare Health (WCG) Beats on Q4 Earnings, Misses Revenues
by Zacks Equity Research
WellCare Health Plans, Inc. (WCG) reported fourth-quarter 2016 adjusted operating earnings of $1.03 per share that missed the Zacks Consensus Estimate of 53 cents by 94%.
The Zacks Analyst Blog Highlights: General Electric, Altria, UnitedHealth, Caterpillar and Phillips 66
by Zacks Equity Research
The Zacks Analyst Blog Highlights: General Electric, Altria, UnitedHealth, Caterpillar and Phillips 66
GNC Holdings (GNC) Q4 Earnings: A Surprise in the Cards?
by Zacks Equity Research
GNC Holdings, Inc. (GNC) -- a specialty retailer of health and nutrition related products -- is scheduled to report fourth-quarter 2016 financial results on Feb 16, before the opening bell.
Top Research Reports for February 6, 2017
by Mark Vickery
Today's Research Daily features new research reports on 16 major stocks, including General Electric (GE), Altria (MO) and UnitedHealth (UNH).
Cigna (CI) Beats Earnings and Revenue Estimates in Q4
by Zacks Equity Research
Cigna Corp. (CI) reported fourth-quarter 2016 operating net earnings of $1.87 per share, which surpassed the Zacks Consensus Estimate of $1.74. However, earnings remained flat year over year.
Top Ranked Momentum Stocks to Buy for February 2nd
by Zacks Equity Research
Here are four stocks with buy rank and strong momentum characteristics for investors to consider today, February 2nd:
Anthem (ANTM) Beats Q4 Earnings and Revenue Estimates
by Zacks Equity Research
Anthem Inc.'s (ANTM) fourth-quarter 2016 adjusted net income per share of $1.76 surpassed the Zacks Consensus Estimate of $1.59 by 10.7%.